TABLE 1 Cases with Discordance between ACIS IHC and PathVysion FISH Assays

From: Aneusomy 17 in Breast Cancer: Its Role in HER-2/neu Protein Expression and Implication for Clinical Assessment of HER-2/neu Status

Chromosome 17 Signals per Cell

HER-2/neu Gene to Chromosome 17 Ratio

Subtotal

 

<2.00

≥2.00

 
 

HER-2/neu Gene

HER-2/Neu Gene

 
 

<4.00 Signals per Cell

≥4.00 Signals per Cell

<4.00 Signals per Cell

≥4.00 Signals per Cell

 

≤1.75

0 (2)

0 (0)

2 (2)

0 (1)

2 (5)

1.76–2.25

3 (67)

0 (0)

0 (0)

4 (25)

7 (92)

2.26–2.75

2 (18)

1 (2)

0 (0)

2 (17)

5 (37)

2.76–3.25

1 (12)

0 (2)

0 (0)

1 (15)

2 (29)

3.26–3.75

1 (4)

0 (5)

0 (0)

0 (7)

1 (16)

≥3.76

0 (1)

0 (1)

0 (0)

0 (8)

0 (10)

Subtotal

7 (104)

1 (10)

2 (2)

7 (73)

17 (189)

  1. The numbers without parentheses represent cases with discordance between ACIS IHC and PathVysion FISH assays, including ones without HER-2/neu gene amplification (ratio of <2.00) but with HER-2/neu protein overexpression (ACIS scores of ≥2.0); and ones with HER-2/neu gene amplification (ratio of ≥2.00) but without HER-2/neu protein overexpression (ACIS scores of <2.0). The numbers in parentheses represent total number of cases in each subset.